Mucosal Vaccines, Adjuvants & Delivery

14-16 September 2016, CHUVUniversity of Lausanne, Lausanne, Switzerland

  • Increase font size
  • Default font size
  • Decrease font size

Day One

Final Conference Programme | Wednesday 14th September 2016

09.30-10.30
Arrival, Registration, Coffee & Poster Set-Up

10.30-10.45
Welcome to Lausanne & Opening Remarks
Richard Walker (PATH, Washington DC, USA)

SESSION 1:
OPENING PLENARY SESSION

Moderator: Richard Walker (PATH, Washington DC, USA)

10.45-11.30
‘Keeping mucosal vaccines and adjuvants in perspective’
Ali Harandi (University of Gothenburg, Gothenburg, Sweden)

11.30-12.15
‘Distinct mechanisms regulate induction of mucosal versus systemic IgA responses’
Martin Bachmann (University of Berne, Berne, Switzerland/University of Oxford, Oxford, UK)

12.15-13.00
‘Parenteral or mucosal immunization against rotavirus and norovirus gastroenteritis?’
Timo Vesikari (University of Tampere, Tampere, Finland)

13.00-14.00
Lunch Break & Posters

SESSION 2:
PLENARY SESSION II

Moderator: Ali Harandi (University of Gothenburg, Gothenburg, Sweden)

14.00-14.30
‘Oral mucosal immunization provides greater breadth of immunity than injected subunit vaccines’
Sean Tucker (VAXART Inc., South San Francisco, California, USA)

14.30-15.00
‘Challenges for achieving intestinal immunization of infants in developing countries’
Richard Walker (PATH, Washington DC, USA)

15.00-15.30
‘Mucosal adjuvants, intranasal delivery and respiratory vaccines. The way forward?’
Rob Lambkin-Williams (hVIVO Ltd, London, UK)

15.30-16.00
Tea Break & Posters

SESSION 3:
DEVELOPMENT

Moderator: Martin Bachmann (University of Berne, Berne, Switzerland/University of Oxford, Oxford, UK)

16.00-16.30
‘Development of an inactivated nasal influenza vaccine’
Anna-Karin Maltais (Eurocine Vaccines AB, Stockholm, Sweden)

16.30-17.00
‘RSV prefusion F-type subunit vaccines’
Maarten van Roosmalen (Mucosis, Groningen, The Netherlands)

17.00-17.30
‘Mucosal delivery of inactivated polio vaccine’
Heleen Kraan 1, Peter Soema 1, Ivo Ploemen 1, Jean-Pierre Amorij 1,# and Gideon Kersten 1,2 (1 Intravacc Institute for Translational Vaccinology, Bilthoven, The Netherlands; 2 Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands; # Current address: Virtuvax BV, The Netherlands)

17.30-18.30
MUCOVAD 2016 Welcome Drinks & Poster Session

 

MUCOVAD 2016 Delegates

Login details will be supplied after you have registered for the event.


MUCOVAD 2016 Sponsors

  • Inovio Pharmaceuticals
  • Aldevron
  • NatureGeneTherapy.com
  • DNAvaccine.com
  • Mucosis
  • Matrivax
  • Vaxart

MUCOVAD 2016 Downloads

MUCOVAD 2016 Leaflet

MUCOVAD 2016 Mailing List

Name
E-mail Address
What is 3+2-1?